Skip to content

The Study on Diagnostic Criteria and Evolution Patterns of Pulmonary Thromboembolism (PTE)

The Study on Diagnostic Criteria and Evolution Patterns of Pulmonary Thromboembolism (PTE)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2025001616
Enrollment
Unknown
Registered
2025-08-28
Start date
2024-11-29
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Thromboembolism

Interventions

Acute Pulmonary Thromboembolism:No Intervention
chronic thromboembolic pulmonary hypertension:No Intervention

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: For PTE Patients: 1.Meet diagnostic criteria for acute pulmonary thromboembolism (PTE) (refer to [ESC/CHEST guidelines]) 2.Age =18 years with complete four diagnostic TCM data (inspection auscultation-olaction inquiry palpation) 3.Signed informed consent form For CTEPH Patients: 1.Meet diagnostic criteria for chronic thromboembolic pulmonary hypertension (CTEPH) (refer to [ERS/ESC guidelines]) 2.History of pulmonary thromboembolism or venous thromboembolism 3.Age =18 years with complete four diagnostic TCM data 4.Signed informed consent form

Exclusion criteria

Exclusion criteria: For PTE Patients: 1.Confirmed non-thrombotic embolism (e.g. fat embolism amniotic fluid embolism air embolism tumor embolism) 2.Refusal to follow-up or inability to collect clinical data due to psychiatric disorders 3.Life expectancy <3 months as judged by investigators For CTEPH Patients: 1.Severe comorbidities involving cardiac cerebral hepatic renal or hematological systems active infectious diseases (hepatitis A/B HIV/AIDS tuberculosis) or active-stage connective tissue diseases 2.Refusal to participate in follow-up visits or inability to cooperate due to psychiatric conditions 3.Current pregnancy planned pregnancy or lactation period

Design outcomes

Primary

MeasureTime frame
Traditional Chinese Medicine Syndrome;

Secondary

MeasureTime frame
Serum Proteins;Serum Metabolites;Computed Tomography Pulmonary Angiography;

Countries

China

Contacts

Public ContactYinji Xu

Guangdong Provincial Hospital of Chinese Medicine

xuyinji@163.com13826173153

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026